New Lundbeck exec to get firm's next research leg started

Lundbeck's executive group used a strict checklist to find its new head of R&D, and Tarek Samad, who will be taking on the job on May 1, scored top marks on one parameter in particular.
Photo: PR / Lundbeck
Photo: PR / Lundbeck
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

Lundbeck's decision to find a new head of research and development is part of a major reorganization of the company's R&D unit, which has been going on for a while, the Danish pharmaceutical firm's Executive Vice President & Head of Research & Development Johan Luthman tells MedWatch.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Related articles:

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading